Bank of Nova Scotia’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-271
Closed -$93.6K 1055
2025
Q1
$93.6K Hold
271
﹤0.01% 967
2024
Q4
$81.3K Hold
271
﹤0.01% 993
2024
Q3
$110K Hold
271
﹤0.01% 950
2024
Q2
$87.1K Buy
+271
New +$88.1K ﹤0.01% 960

Other funds holding HCA

Bank of Nova Scotia's HCA Position: Q1 2026 in Review

Bank of Nova Scotia increased its HCA Healthcare (HCA) stake by 50% in Q1 2026, buying an estimated $6.42M and bringing the position to 38,031 shares worth $18M. The position accounts for 0.03% of the portfolio, ranked #317.

Bank of Nova Scotia first reported a position in HCA in Q2 2014 and has held it in 47 quarters since. The position peaked at $91.2M in Q3 2020. 1,418 funds tracked by Wall St. Rank hold HCA as of Q1 2026.

  • Bank of Nova Scotia held 38,031 shares of HCA Healthcare worth $18M as of Q1 2026.
  • Bank of Nova Scotia bought 12,749 HCA Healthcare shares in Q1 2026, an estimated $6.42M.
  • HCA Healthcare made up 0.03% of Bank of Nova Scotia's portfolio in Q1 2026, its #317 holding.
  • Bank of Nova Scotia first reported a position in HCA Healthcare in Q2 2014 and has held it in 47 quarters since.
  • Bank of Nova Scotia's HCA Healthcare position peaked at $91.2M in Q3 2020.
  • 1,418 funds tracked by Wall St. Rank held HCA Healthcare as of Q1 2026.

Based on Bank of Nova Scotia's 13F filing for Q1 2026, filed 14 May 2026.